BioRestorative Therapies, Inc.
BRTX
$0.18
-$0.01-6.38%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 66.10% | -96.11% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 66.10% | -96.11% | |||
| Cost of Revenue | -84.91% | 21.84% | |||
| Gross Profit | 1,400.00% | -99.59% | |||
| SG&A Expenses | 9.02% | -18.81% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.34% | 3.11% | |||
| Operating Income | -3.14% | -12.21% | |||
| Income Before Tax | -5.57% | -14.38% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -5.57% | -14.38% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -5.57% | -14.38% | |||
| EBIT | -3.14% | -12.21% | |||
| EBITDA | -3.18% | -12.42% | |||
| EPS Basic | 1.26% | -9.67% | |||
| Normalized Basic EPS | 1.25% | -9.69% | |||
| EPS Diluted | 1.26% | -9.67% | |||
| Normalized Diluted EPS | 1.25% | -9.69% | |||
| Average Basic Shares Outstanding | 6.91% | 4.30% | |||
| Average Diluted Shares Outstanding | 6.91% | 4.30% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||